ORIGINAL RESEARCH article
A Global Analysis of Kinase Function in Candida albicans Hyphal Morphogenesis Reveals a Role for the Endocytosis Regulator Akl1
- 1B. Rappaport Faculty of Medicine, Technion – Israel Institute of Technology, Rappaport Institute for Research in the Medical Sciences, Haifa, Israel
- 2Institut für Molekulare Infektionsbiologie, Universität Würzburg, Würzburg, Germany
- 3Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, Institute Biology Valrose, Université Côte d'Azur, Nice, France
The human pathogenic fungus Candida albicans can switch between yeast and hyphal morphologies as a function of environmental conditions and cellular physiology. The yeast-to-hyphae morphogenetic switch is activated by well-established, kinase-based signal transduction pathways that are induced by extracellular stimuli. In order to identify possible inhibitory pathways of the yeast-to-hyphae transition, we interrogated a collection of C. albicans protein kinases and phosphatases ectopically expressed under the regulation of the TETon promoter. Proportionately more phosphatases than kinases were identified that inhibited hyphal morphogenesis, consistent with the known role of protein phosphorylation in hyphal induction. Among the kinases, we identified AKL1 as a gene that significantly suppressed hyphal morphogenesis in serum. Akl1 specifically affected hyphal elongation rather than initiation: overexpression of AKL1 repressed hyphal growth, and deletion of AKL1 resulted in acceleration of the rate of hyphal elongation. Akl1 suppressed fluid-phase endocytosis, probably via Pan1, a putative clathrin-mediated endocytosis scaffolding protein. In the absence of Akl1, the Pan1 patches were delocalized from the sub-apical region, and fluid-phase endocytosis was intensified. These results underscore the requirement of an active endocytic pathway for hyphal morphogenesis. Furthermore, these results suggest that under standard conditions, endocytosis is rate-limiting for hyphal elongation.
Phosphorylation, the most prevalent post-translational modification of cellular proteins, can modify protein conformation or protein-protein interactions, and as a consequence can alter the enzymatic activity of proteins, their localization, or their stability. Protein phosphorylation is essential to signal transduction, e.g., of extracellular stimuli to cellular proliferation or differentiation programs. The central role that kinases and phosphatases play in cellular regulation is reflected in their prevalence: kinases constitute about 2 percent of genes in both the human and the budding yeast (S. cerevisiae) genomes (Hunter and Plowman, 1997; Manning et al., 2002).
One of the many developmental processes where protein phosphorylation was shown to play a key role is the yeast to hyphae transition in the pathogenic yeast Candida albicans. C. albicans is the most common systemic fungal pathogen in developed countries, responsible for several hundred thousand deaths each year, chiefly among immunocompromised patients (Brown et al., 2012). Like several other fungal pathogens, C. albicans is able to assume different morphologies under different conditions (Sudbery et al., 2004). Whereas in normal growth medium it proliferates as yeast cells, increased temperature and exposure to stimuli such as serum or N-acetylglucosamine induces C. albicans to form hyphae. The signal transduction pathways that mediate hyphal induction have been thoroughly explored, and found to include transmission of extracellular signals via Ras to both protein kinase A and the MAP kinase cascade (Leberer et al., 1996; Feng et al., 1999; Biswas and Morschhäuser, 2005; Maidan et al., 2005). These signaling pathways result in the activation of a number of transcription factors such as Efg1 (Stoldt et al., 1997) and Ume6 (Banerjee et al., 2008; Zeidler et al., 2009) and inactivation of the transcriptional repressor Nrg1, which needs to be removed from hyphal-specific gene (HSG) promoters in order to allow induction of hyphal morphogenesis (Braun et al., 2001; Murad et al., 2001; Lu et al., 2011). Beyond signaling pathways, effective hyphal development requires alterations in many cellular functions; for example, growth of hyphae requires an active endocytic pathway, possibly in order to counterbalance the loss of membrane and proteins by exocytosis at the hyphal tip (Shaw et al., 2011).
Alongside pathways for hyphal induction, there are also mechanisms that suppress hyphal morphogenesis, such as protein degradation via the ubiquitin ligases Ubr1 and SCFCaCDC4 of the transcription factors Cup9 and Ume6, respectively (Atir-Lande et al., 2005; Lu et al., 2014; Mendelsohn et al., 2017). With regard to protein phosphorylation, while its activating roles in hyphal morphogenesis have been extensively investigated, less attention has been given to possible negative functions of protein phosphorylation in this process. In order to globally interrogate the potential role of protein phosphorylation in the suppression of hyphal morphogenesis, we took advantage of a collection of all identifiable kinase and phosphatase genes, as well as kinase and phosphatase regulators, cloned under the inducible TETon promoter. Using this collection, we identified kinase Akl1 among several potential novel regulators of hyphal morphogenesis. Candida albicans Akl1 was found, like its S. cerevisiae homolog, to repress endocytosis via its effect on the epsin homolog Pan1, a scaffolding protein linking the actin cytoskeleton to sites of clathrin-mediated endocytosis (Wendland and Emr, 1998; Takahashi et al., 2006; Bradford et al., 2015; Sun et al., 2015). The results shown here further underscore the relation between hyphal morphogenesis and the endocytic pathway, and suggest that hyphal elongation can be regulated via modulation of endocytosis.
Materials and Methods
All experiments were performed in YEP medium (1% Difco Yeast Extract, 2% Difco Bacto-peptone) supplemented with L-Tryptophan (0.15 g/l) and uridine (0.05 g/l), and either 2% glucose (= YPD) or 2% maltose or 2% raffinose, as indicated. Fetal bovine serum (Biological Industries, Israel) was added to 10% where indicated. For induction of the TETon promoter, doxycycline was added to 50 μg/ml. Selection for transformation with plasmids carrying auxotrophic markers was carried out on YNB plates supplemented with each amino acid and uridine, adenine at 0.1 g/l except leucine (0.3 g/l), but lacking the precursor used for selection.
Plasmid and Strain Construction
The kinase and phosphatase library under the regulation of the TETon promoter is based on a library described previously (Ramírez-Zavala et al., 2013), to which we added 9 new kinase clones. In addition, the previously published library did not contain phosphatases; here we added 49 phosphatase genes, for a total of 222 genes (Supplementary Table 1). The MKK2 S317A T321A allele is a predicted dominant-negative allele, based on the phenotype of the corresponding mutations in human MEK5 (S311A T315A), which abolish the activating phosphorylation sites of this MEKK (Sun et al., 2001). The PBS2 K233A allele was modeled after the equivalent allele of its closest human homolog, MEK1 K97A, which displays a dominant-negative phenotype (Seger et al., 1994). CLN3ΔC has a nonsense mutation at codon 332, removing the C-terminal 133 residues of C. albicans Cln3, and yielding an expected stabilized and hyperactive protein, similar to the S. cerevisiae CLN3 alleles DAF1-1 and WHI1-1 (Cross, 1988; Nash et al., 1988). KB2213 contains the open reading frame (ORF) of AKL1 (−1 to + 2418) cloned HindIII-ApaI into KB1817 (Ofir et al., 2012). KB2301 contains AKL1 (from −470 to +2418) cloned NotI-HindIII into pBES116 (Feng et al., 1999). KB2381 contains the AKL1 ORF (−1 to + 2418) cloned EcoRV-KpnI under the MAL2 promoter of pBES119 (Feng et al., 1999). KB2391 contains the PAN1 ORF (−1 to +4188) cloned SmaI-XhoI into KB2083 (Ofir et al., 2012) cut EcoRV-SalI. KB2434 contains the 3′ end of the PAN1 ORF (+268 to +4188) cloned BamHI-XhoI into KB2430, itself containing the GFPgamma + URA3 fragment of pFA-GFPγ-URA3 (Zhang and Konopka, 2010) cloned XhoI-KpnI into pBSII-SK+ (Stratagene).
The C. albicans strains are listed in Table 1. KC553, KC554 were generated by PCR-mediated deletion of AKL1 alleles (Noble and Johnson, 2005). KC651 contains the MAL2 promoter of plasmid pFA-URA3-MAL2p (Gola et al., 2003) integrated upstream of the UME6 open reading frame by PCR-targeted recombination. KC816, KC817 contain the vector plasmid KB1817 and KB2213 (HIS1 MAL2-AKL1) respectively. KC824, KC825 contain the vector plasmid BES116 and KB2301 (AKL1) respectively. KC840, KC841 contain the vector plasmid BES116 and KB2381 (URA3 MAL2-AKL1). KC850, KC851 contain the vector plasmid pBES119 and KB2381, respectively. KC857 and KC869 contain plasmid KB2391. KC862 contains plasmids KB2213 and pBES119, while KB863 contains KB2213 and KB2391. KC868 contains vector plasmid BES116. KC908 and KC909 were constructed by integrating GFP of plasmid KB2434 downstream of PAN1. KC919, KC920 contain vector plasmid KB1817 and plasmid KB2213, respectively. KC983 and KC984 were constructed by integrating PAN1-3xHA into a PAN1 allele using KB2391 digested with HindIII, which cuts in the middle of the PAN1 ORF. KC987, KC988 contain vector plasmid BES119 and KB2391, respectively. KC1062, KC1063 contain vector plasmid KB1817 and plasmid KB2213, respectively.
WO-1 cells transformed with the TETon kinase library (Ramírez-Zavala et al., 2013) were grown overnight at 30°C in YPD in 96-well plates, then diluted 1:5 in YPD + 10% fetal bovine serum, 50 μg/ml doxycycline, in 96-well plates (150 μl/well) and incubated at 30°C for 5.5 h. Cells were then fixed with 4% formaldehyde and observed microscopically for morphology. Morphology was scored between −4 (no hyphae at all) and +4. The experiment was repeated 3 times; Supplementary Table 1 indicates the average score for each clone.
DIC micrographs were taken with a Zeiss AxioImager.M1 equipped with 40X and 100X objectives. For measurements of hyphal length, cells were fixed with 70% ethanol, then pelleted and resuspended in 2% H2SO4 to reduce cell clumping. Lengths were measured with the Axiovision software measuring function. The person performing the measurements was blinded to the identity of the cultures. Statistical analysis of cell size distributions (t-test, regression analysis) was performed using Microsoft Excel's analysis package.
For visualization of Pan1-GFP, cells were fixed by addition of formaldehyde to 2% and incubating 10 min at 30°C in a roller. The cells were then washed twice with phosphate-buffered saline (PBS), separated by repeated aspiration through a 29G needle and resuspended in Vectashield mounting medium. A Zeiss LSM700 confocal system was used to gather images. The micrographs in Figure 6 represent a maximum intensity projection of a full fluorescence Z-stack overlaid upon a DIC micrograph. Quantitation of the Pan1-GFP signals as a function of the distance from the hyphal tip was achieved using the Bitplane Imaris 9.0.1 software's spots detection function. The threshold was set such that non-tagged control cells displayed 1 or 2 spots at most, whereas tagged cells usually displayed between 30 and 120 spots.
Fluid-Phase Endocytosis Assay
Lucifer Yellow (LY) uptake was used as a measure of fluid-phase endocytosis (Basrai et al., 1990; Dulic et al., 1991). Overnight cultures were diluted to the appropriate medium and grown 2–3 h to an OD600 of 0.1. For each assay, 10 ml of the culture was spun down (3,500 g, 5′) and resuspended in 0.9 ml of fresh medium. 0.1 ml of Lucifer Yellow CH (LY; Sigma), 40 mg/ml in water, was added and the cultures were incubated another 1 h while shaking. The cells were then spun down, resuspended in 1 ml ice-cold stop buffer (50 mM Succinate-NaOH, pH 7.5, 100 mM NaCl, 10 mM NaN3, 10 mM MgCl2), and spun down again a total of 6 times. The final pellet was resuspended in 1 ml lysis buffer (50 mM Tris-Cl Ph 7.5 m 10 mM 2-mercaptoethanol, 2,000 U lyticase (Sigma)/ml) and incubated 15′ at 37°C. LY fluorescence was quantitated using a Tecan Infinite M200 PRO spectrofluorimeter with 426 nm excitation and 550 nm emission. Fluorescence was calibrated with free LY in the same buffer. To normalize LY uptake to cell amount, the protein amount was measured by the Bradford method (Bio-Rad protein assay dye reagent), using 0.2 ml of the same extract used for LY quantitation. Bovine serum albumin (Sigma) was used for calibration of the protein assay. Since even the normalized LY uptake was highly sensitive to incubation conditions and LY batch, only assays carried out together could be directly compared.
Pan1 Protein Analysis
For Western blotting, 1.5 ml culture samples (~1.5 O.D600 cells) were spun down, resuspended in 0.5 ml 0.25M NaOH, 1% 2-mercaptoethanol, incubated on ice 10 min, then precipitated on ice with 7% trichloroacetic acid. The pellets were washed with ice-cold acetone and resuspended in gel loading buffer, separated by SDS-PAGE (BioRad 4–20% prepoured gels), transferred to nitrocellulose, and detected with HA.11 (Covance) and anti-β-actin (Sigma). 35S-methionine pulse-chase analysis was carried out essentially as described (Kornitzer, 2002). Briefly, 10 ml cultures (O.D600 ~ 1) were washed twice with 0.4 ml YNB medium + 2% maltose and resuspended in the same medium + 1 mCi Express labeling mix (Perkin-Elmer), incubated 7 min at 30°C, then spun down and resuspended in 2.5 ml synthetic complete medium + 10 mM methionine, cysteine. 0.6 ml aliquots retrieved at indicated times were treated with 0.25M NaOH, 1% 2-mercaptoethanol, then precipitated on ice with 7% trichloroacetic acid. The pellets were washed with acetone, resuspended in 2.5% SDS, 5 mM EDTA, and equal amounts of incorporated radioactivity were immunoprecipitated by diluting the extract at least 10-fold in i.p. buffer (50 mM Na-Hepes pH 7.5, 0.15 M NaCl, 5 mM Na-EDTA, 1% Triton X-100, 1 mM PMSF, HA.11 (Covance) 1 μg/m) and adding Protein A sepharose CL-4B (GE Healthcare).
Identification of Genes that Suppress Hyphal Morphogenesis
A collection of over 200 protein kinases, phosphatases, and some ancillary factors (see Methods), expressed in the C. albicans WO-1 strain under the TETon promoter, was screened for genes that inhibited hyphal morphogenesis. For each gene, two independently transformed strains were assayed by diluting an overnight culture into YPD + 10% fetal calf serum at 30°C, and monitoring hyphal morphogenesis (Supplementary Table 1). Table 2 lists 32 genes that consistently reduced hyphal formation to greater or lesser extent, 16 kinases or kinase-associated proteins (e.g., cyclins) and 16 phosphatases or phosphatase-associated proteins. Since the collection contained only 22% phosphatases (and associated proteins), the phosphatase representation in the hyphal morphogenesis-suppressing genes was significantly higher than expected (binomial probability = 3 × 10−4), consistent with the well-studied role of kinases in the signal transduction pathways leading to hyphal morphogenesis. Specific phosphatases in this set that were previously shown to affect hyphal morphogenesis include PSR1 (Elson et al., 2009), PTC1 (Hanaoka et al., 2008), SHP1 and GLC7 (Hu et al., 2012), PPG1 (Albataineh et al., 2014), and PPH3 (Sun et al., 2011).
Among the kinases and associated proteins, a number of genes previously implicated in hyphal morphogenesis were also found, e.g., Snf4 (Uhl et al., 2003) which, together with the upstream activating kinase Sak1 and the β-subunits Kis1 and Kis2, regulates Snf1 kinase activity (Corvey et al., 2005; Ramirez-Zavala et al., 2017); the Pho85 cyclin Pcl5, a regulator of the transcription factor Gcn4 (Gildor et al., 2005); the Cdc28/Cdk1 cyclin Cln3 (Bachewich and Whiteway, 2005; Chapa Y Lazo et al., 2005; Zeng et al., 2012; Mendelsohn et al., 2017) and the Cdc28/Cdk1 inhibitor Sol1 (Atir-Lande et al., 2005); the MAPKK Pbs2 (Arana et al., 2005); and the Nim1 kinase Hsl1 (Wightman et al., 2004; Umeyama et al., 2005). Other genes have homologs involved in hyphal morphogenesis in filamentous fungi, e.g., Bud32, a homolog of Aspergillus nidulans pipA (Kempf et al., 2013); and Rim15, a homolog of N. crassa stk-12 (Watters et al., 2011).
The Kinase Akl1 Suppresses Hyphal Morphogenesis
One of the kinases that gave the strongest suppression of hyphae formation, Akl1, had not previously been identified as being involved in hyphal morphogenesis. We thus first confirmed the effect of Akl1 in the standard laboratory strain SC5314. Since our TETon promoter is less active in SC5314 than in WO-1 background, we switched to an alternative overexpression system, by placing the AKL1/19.5357 open reading frame under the regulation of the maltose-induced MAL2 promoter, which yielded a 4–5-fold increase in AKL1 mRNA (see below, Figure 8), and expressing it in the CAI4 strain background (Fonzi and Irwin, 1993). AKL1 suppressed hyphal growth in this system as well (Figure 1A).
Figure 1. Hyphal morphogenesis in cells overexpressing AKL1 or deleted for AKL1. (A) Micrographs of wild-type cells carrying a vector plasmid (KC840) vs. the MAL2-AKL1 construct (KC841). Overnight cultures were diluted in YEP + 2% maltose + 10% FCS and incubated 3 h at 37°C. (B) A strain containing a MAL2 promoter upstream of the UME6 ORF was transformed with either a vector plasmid (KC919) or the MAL2-AKL1 construct (KC920). An overnight culture was diluted in YEP + 2% maltose and incubated for 7 h at 30°C. (C) Comparison of hyphal induction in wild-type (KC274) and akl1−/− deletion (KC554) under the indicated conditions. Overnight cultures were diluted in YPD with or without 10% FCS. (D) The indicated akl1−/− deletion and reintegrant strains (KC824 and KC825) were grown overnight at 37°C in YPD + 10% serum. The tubes were vigorously vortexed, then left to sediment for 30 min.
Hyphal morphogenesis depends on activation of a number of signal transduction pathways that culminate with the induction of the UME6 gene (Banerjee et al., 2008; Zeidler et al., 2009). Ume6 is a transcription factor that activates genes essential for hyphal morphogenesis, and it is itself both necessary and sufficient for hyphal morphogenesis (Carlisle et al., 2009). In order to distinguish whether Akl1 interferes with hyphal induction by blocking UME6 induction, or by interfering with cellular functions induced by Ume6, we artificially induced hyphal morphogenesis by ectopically expressing Ume6 under the MAL2 promoter, with or without co-expression of AKL1 under MAL2 (Figure 1B). Co-overexpression of AKL1 significantly reduced the extent of hyphal elongation induced by Ume6 overexpression, suggesting that Akl1 exerts its effect either post-transcriptionally on Ume6 itself, or by interfering with cellular mechanisms required for hyphal morphogenesis.
Since overexpression of AKL1 suppressed hyphal growth, we next tested the phenotype of the deletion of AKL1 on morphogenesis. We deleted both alleles of AKL1, followed by reintegration of a wild-type allele in the deletion strain. Compared to the wild-type strain, the deletion strain exhibited more robust hyphal growth, best detected under sub-optimal hyphal induction conditions, such as a shift to 37°C in regular YPD medium, but also visible in optimal hyphal induction conditions, 37°C + 10% serum (Figure 1C). This difference in hyphal induction was also visible after overnight growth of the different strains under hyphal induction conditions: when comparing the akl1−/− deletion strain with the same strain containing a reintegrated wild-type AKL1 allele, longer hyphae were visible in the akl1−/− deletion strain. Macroscopically, this was expressed as a non-sedimenting mycelium that filled the whole tube. In contrast, the reintegrant strain sedimented rapidly, as usually observed with hyphal C. albicans cultures (Figure 1D).
Characterization of the Effect of Akl1 on Hyphal Morphogenesis
Microscopic observation of cells after a few hours' growth in hypha-inducing conditions showed shorter hyphae in cells overexpressing AKL1 (Figure 1A). Conversely, the akl1−/− mutant displayed longer hyphae, compared to the wild-type (Figure 1C). In order to quantitate these effects, and to dissociate potential effects of Akl1 on hyphal germ tube induction from effects on hyphal elongation, wild-type cells overexpressing AKL1 under the MAL2 promoter were subjected to hyphal induction by shift to 37°C, without or with addition of 10% serum, and germ tube proportion and length were measured at fixed time intervals after induction (Figure 2). In a parallel experiment, cultures of the wild-type and mutant AKL1 strains were similarly compared (Figure 3), as well as of the AKL1 mutant vs. reintegrant strain (Supplementary Figure 1). Analysis of the data indicates that the extent of germ tube induction was unaffected by Akl1 activity (Figures 2A, 3A). In contrast, the rate of germ tube elongation was significantly affected by Akl1 activity. In cells overexpressing AKL1, hyphal extension rates between 1 and 4 h after shift to 37°C were reduced by 29 and 44% in medium with or without serum, respectively (Figure 2B). In the absence of AKL1, conversely, an increase in hyphal extension rate was detected. However, the effect was biphasic: within the first hour after shift to 37°C, in both the presence and absence of serum, an increase of 60% in hyphal length was detected in the akl1−/− strain (Figure 3B, 60 min time point). During the second hour after induction, in the presence of serum, no additional increase in the difference between akl1−/− and AKL1 hyphal lengths was detected, indicating that the hyphal extension rates had equalized, whereas in the absence of serum, the akl1−/− strain still exhibited a 24% faster hyphal elongation rate (Figure 3, 60–120 min time points). Notably, deletion of AKL1, or overexpression of AKL1 under the MAL2 promoter, had no detectable impact on growth at 37°C (Supplementary Figure 2).
Figure 2. AKL1 overexpression suppresses the rate of hyphal elongation. (A) Wild-type cells containing a URA3 vector plasmid (KC840) or a URA3 MAL2-AKL1 plasmid (KC841) were grown overnight in YEP + 2% raffinose, then diluted in YEP + 2% maltose at 37°C, with or without 10% serum, as indicated. Samples were retrieved and fixed at the indicated times and the proportion of germ tubes was determined by microscopic observation. Six hundred cells were counted in each culture. (B) Length of germ tubes was measured in the same cultures as for (A). Hundred cells were measured for each condition. The differences between each vector and MAL2-AKL1 pair were all highly significant by Student's t-test (p < 10−4).
Figure 3. Hyphal elongation rate is increased in the akl1−/− mutant. (A) Wild-type (KC 274) vs. akl1−/− (KC554), germ tube induction. An overnight culture was diluted in YPD at 37°C, with or without 10% serum, as indicated. Samples were fixed at the indicated times and the proportion of germ tubes was determined by microscopic observation. Six hundred cells were counted in each culture. (B) Length of germ tubes was measured in the same cultures as for (A). Hundred cells were measured for each condition. The error bars indicate the standard deviations. All differences were highly significant by Student's two-tailed t-test (*p < 10−15).
Effect of Akl1 on Endocytosis
Based on sequence homology, C. albicans Akl1 is related to the Ark/Prk family of kinases (Smythe and Ayscough, 2003), and is more distantly related to the Polo-like kinases (Cdc5). The S. cerevisiae genome contains two Ark/Prk homologs and a single Akl1 homolog, whereas the C. albicans genome contains one homolog of each (Figure 4A). Akl1 was shown to reduce fluid-phase endocytosis when overexpressed from a high-copy plasmid in S. cerevisiae (Takahashi et al., 2006). We therefore tested whether overexpression of Akl1 would likewise reduce fluid-phase endocytosis in C. albicans. LY uptake was monitored in cells overexpressing Akl1 under the MAL2 promoter vs. control cells, and in wild-type vs. akl1−/− cells. LY uptake was reduced in cells overexpressing Akl1 (Figure 4B), and it was enhanced in akl1−/− cells, compared to the wild-type and reintegrant strains (Figure 4C; we noticed that reintegration of AKL1 at the ADE2 locus resulted, both here and in Supplementary Figure 1, in a phenotype consistent with partial overexpression, which could be due to a gene position effect). We thus conclude that Akl1 functions as a repressor of fluid-phase endocytosis.
Figure 4. CaAkl1 is a repressor of fluid-phase endocytosis. (A) Homology tree of the Polo and Ark/Prk kinases of S. cerevisiae and C. albicans aligned using T-COFFEE (Di Tommaso et al., 2011). (B) LY uptake in wild-type cells overexpressing AKL1 under the MAL2 promoter (KC 817) vs. vector plasmid (KC816). (C) LY uptake in wild-type (KC274) cells, the AKL1+/− heterozygote (KC553), the akl1−/− deletion homozygote (KC554), akl1−/− with vector plasmid (KC824) or with AKL1 plasmid (KC825). Overnight cultures were shifted from YEP + 2% raffinose to YEP + 2% maltose (B) or diluted in YPD (C) and incubated at 37° for 2.5 h before carrying out the assays. The error bars indicate the standard deviation between three independent cultures.
However, we noted that the effect of Akl1 on LY uptake was reduced at 30°C compared to 37°C (data not shown). Since hyphal morphogenesis is induced in the control cells at 37°C, and suppressed by Akl1 activity, it was possible that hyphae are more active in endocytosis than yeast cells, and that Akl1 indirectly suppresses endocytosis by suppressing hyphal morphogenesis. To rule out this possibility, we overexpressed Akl1 in the ume6−/− mutant, which is unable to form hyphae (Banerjee et al., 2008; Zeidler et al., 2009). In these cells as well, Akl1 overexpression caused a decrease in LY uptake (Supplementary Figure 3), indicating that Akl1's effect on endocytosis is not an indirect consequence of its effect on hyphal morphogenesis.
Akl1 Induces Post-translational Modification of C. albicans Pan1
Pan1 is a yeast clathrin-mediated endocytosis scaffold protein, homologous to mammalian Intersectin. Its closest C. albicans homolog was previously suggested to be essential for endocytosis in this organism as well (Martin et al., 2007). Since there was evidence that S. cerevisiae Akl1 phosphorylates Pan1 in vivo (Takahashi et al., 2006), we tested whether C. albicans Pan1 was differentially post-translationally modified in the absence of AKL1, or under AKL1 overexpression. Migration of epitope-tagged Pan1 on SDS-PAGE followed by Western blotting showed a main band with a slower-migrating “smear” above it, typical of phosphoryated species (Figure 5A). The slower-migrating species were not visible in the akl1−/− strain, and conversely, they represented a larger fraction of total Pan1 in cells overexpressing AKL1 (Figure 5A). Furthermore, the steady-state levels of Pan1 were elevated in the absence of AKL1 (Supplementary Figure 4). In order to measure the stability of Pan1 as well as to follow the dynamics of the appearance of these slower-migrating species, the cells were subjected to pulse-and-chase analysis with 35S-methionine (Figure 5B). Whereas no change in the main Pan1 band was visible in the akl1−/− strain, a slower-migrating species gradually appeared in the wild-type strain. This slower-migrating species reached a steady-state level after about 30 min, where it constituted a majority of Pan1. However, we detected no effect of the AKL1 genotype on Pan1 stability.
Figure 5. Akl1 induces modification of Pan1. (A) Western blot analysis of Pan1-3xHA expressed under its endogenous promoter in AKL1+/+ (KC1062) and akl1−/− (KC984) cells, or in AKL1+/+ cells expressing AKL1 under the MAL2 promoter (KC1063). Cells (2 clones of each genotype) were grown overnight in YEP-raffinose, then shifted to YEP-2% maltose for 4 h. Extracts were migrated on a 6% SDS-PAGE gel. (B) Pulse-chase analysis of Pan1-3xHA expressed under the MAL2 promoter in AKL1+/+ (KC 869) and akl1−/− cells (KC857). Cells were grown overnight in YEP-raffinose, then shifted to YEP-2% maltose for 3 h before pulse-labeling with 35S-methionine, followed by a chase with cold methionine for the indicated amounts of time. C = no-tag control.
Since these experiments were performed in maltose medium, we also tested whether the AKL1 genotype affected the Pan1 protein in glucose medium. As shown in Supplementary Figure 5, a similar decrease in slower-migrating species of Pan1 was detected in the akl1−/− mutant grown in glucose, but the effect on Pan1 steady-state levels was much reduced in this medium.
Akl1 Affects C. albicans Pan1 Localization
S. cerevisiae Pan1 was shown to localize to dynamic patches on the cell surface, together with other proteins associated with clathrin-mediated endocytosis (Wendland and Emr, 1998; Kaksonen et al., 2003, 2005). In C. albicans hyphal cells, the Pan1 homolog was found to be distributed along the length of the hyphae, but with higher concentration toward the apex (Martin et al., 2007). We assayed whether Akl1 influences C. albicans Pan1 localization by visualizing a Pan1-GFP fusion protein in wild-type vs. akl1−/− cells. Consistent with previous observations (Martin et al., 2007), we also find that Pan1-GFP is mostly localized sub-apically in wild-type cells. In akl1−/− cells however, it is delocalized and is more broadly distributed along the length of the hyphae (Figure 6). This broader distribution might explain the more active endocytosis detected in the akl1−/− cells (Figure 4).
Figure 6. Pan1 patches are delocalized in the absence of Akl1. Pan1-GFP is expressed under its endogenous promoter in the wild-type (KC908) or akl1−/− cells (KC909), or the non-tagged wild type strain. (A) The GFP signal was visualized by confocal microscopy in cells fixed 2 h after hyphal induction by a shift to 37°C in YPD + 10% FCS. (B) The graph represents the percentage of Pan1-GFP spots within 2 μm of the hyphal tip, relative to the total number of spots in that hypha. N = 27 (AKL1), 30 (akl1−/−), p < 10−3.
PAN1 Overexpression Antagonizes the Effect of Akl1 Overexpression on Hyphal Morphogenesis and Endocytosis
If reduction of Pan1 activity in endocytosis is responsible for the reduced hyphal morphogenesis in the presence of overexpressed Akl1, then it may be possible to suppress the effect of Akl1 on hyphal morphogenesis by increasing Pan1 activity. To test this, we co-overexpressed Pan1 and Akl1 alone and together, and monitored hyphal elongation upon shift to 37°C. As shown in Figure 7, the suppression of hyphal morphogenesis by Akl1 was canceled by co-overexpression of Pan1. This is consistent with the possibility that Pan1 is the main target of Akl1 in the hyphal morphogenesis suppression mechanism. The effects of the expression of these genes on the time of germ tube appearance was minor and could not account for the differences in hyphal elongation (Supplementary Figure 6).
Figure 7. Pan1 is antagonistic to Akl1 for suppression of hyphal morphogenesis and endocytosis. Overnight cultures of wild-type cells containing the MAL2-AKL1 construct (KC817) or the MAL2-PAN1 construct (KC869) separately, or both plasmids together (KC863), or just the vector plasmid (KC868), were diluted in YEP-2% maltose at 37°C. (A) Micrographs of the four cultures after 3 h growth. (B) Measurement of 100 germ tubes each of the cultures after 2 and 3 h growth at 37°C. The bars indicate the average germ tube lengths, the error bars indicate the standard deviations, and the asterisks indicate statistical significance (Student's two-tailed t-test) of the difference for each individual culture compared to the vector control. *p < 0.05, **p < 10−6, ***p < 10−15. (C) LY uptake in the same transformants. The bars indicate the average of 3 cultures each, and the error bars indicate the standard deviations.
Interestingly, overexpression of PAN1 by itself led to faster hyphal elongation (Figures 7A,B). We therefore tested whether, similar to the AKL1 deletion, PAN1 overexpression also caused an increase in LY uptake. Cells that overexpress PAN1 do in fact show higher levels of LY uptake (Figure 7C). AKL1 overexpression caused reduction in LY uptake (Figure 7C), as shown before (Figure 4B), whereas expression of both genes together restored wild-type levels of LY uptake (Figure 7C). In order to dissociate the effect of Pan1 on endocytosis and on hyphal morphogenesis, we used the ume6−/− mutant, which does not form hyphae, as before. We found that PAN1 overexpression still increased LY uptake in the ume6−/− mutant (Supplementary Figure 7), indicating that the effect of PAN1 overexpression on endocytosis is not a consequence of its effect on hyphal elongation.
PAN1 and AKL1 Affect the Expression of Hyphal-Specific Genes
We tested the effect of PAN1 overexpression and of AKL1 overexpression and deletion on hyphal-specific gene (HSG) expression, using the representative HSGs HWP1 and ECE1. As shown in Figure 8, HWP1 and ECE1's expression was well correlated with the morphology of the cells (Figures 1, 7): cells lacking AKL1 or cells overexpressing PAN1, which showed a stronger hyphal morphogenesis, also exhibited higher HSG expression, whereas cells overexpressing AKL1, which showed a reduction in hyphal morphogenesis, exhibited lower HSG expression. Co-overexpression of PAN1 and AKL1 resulted in HSG expression similar to that of the control cells, consistent with the restored hyphal morphology observed in these cells (Figure 7). We also measured the PAN1 and AKL1 levels in the same cells, to confirm that their expression levels are increased as expected when expressed under the MAL2 promoter. We found a 5-fold higher level of AKL1 mRNA in cells containing an additional AKL1 copy expressed under the MAL2 promoter, whereas PAN1 exhibited only 50% higher mRNA levels in the added presence of MAL2-PAN1 in the cells.
Figure 8. Effect of Akl1 and Pan1 on HSG expression. The strains used were the akl1−/− deletion together with a vector plasmid (KC824), or wild-type with a vector plasmid (KC868), with PAN1 under the MAL2 promoter (KC869), with AKL1 under the MAL2 promoter (KC817), or with both AKL1 and PAN1 under the MAL2 promoter (KC863). Overnight cultures were diluted in YEP-2% maltose and grown for 5 h at 37°C. Two independent cultures were assayed for each strain. The bar graph depicts the average of the two cultures. The Northern blots are shown in Supplementary Figure 8.
In order to identify new post-translational repression mechanisms of fungal morphogenesis, we interrogated a comprehensive collection of kinases and phosphatases placed under the regulation of the TETon promoter. While this collection likely contains the vast majority of the kinase and phosphatase gene complement of C. albicans, it should be stressed that ectopic expression of a gene does not necessarily cause activation. Post-transcriptional control mechanisms, as well as post-translational mechanisms such as phosphorylation of MAP kinases, are often essential for full activation of a gene product. Thus it is likely that our screen only interrogated a fraction of the genes represented in the collection. Nonetheless, some general observations can be made. Most striking, a larger proportion of phosphatases was identified among the genes that inhibited hyphal morphogenesis. While this is consistent with the preponderant role that kinase-based signal transduction pathways play in the induction of hyphal morphogenesis, this result also highlights the potentially important but little-studied role that phosphatases may play in restricting hyphal induction under physiological conditions. Although a few examples are known of specific phosphatases that affect C. albicans hyphal morphogenesis, such as Sit4 (Lee et al., 2004) or the Protein Phosphatase 2A homolog Ppg1 (Albataineh et al., 2014), the relatively lower substrate specificity of phosphatases compared to kinases has traditionally made the roles of specific phosphatases harder to assess. It is possible that this lower specificity of phosphatases results in an overlap of target distribution of the phosphatases, causing loss-of-function deletion mutations to have fewer phenotypic effects. The screen presented here overcomes this problem by being based on ectopic gene overexpression and thus on gain of function, or more generally “dominant” effects. The results presented here are a useful reminder of the potential role of phosphatases in the regulation of fungal morphogenesis.
Among the kinases, several had previously been characterized as being involved in hyphal morphogenesis. We chose to focus on Akl1 because it was uncharacterized, exhibited one of the strongest effects on hyphal formation but did not affect yeast proliferation, and because the deletion of AKL1 had the opposite effect, i.e., it enhanced hyphal morphogenesis. Candida albicans AKL1 was found, like its S. cerevisiae counterpart, to regulate endocytosis. Another gene identified in our screen, CLN3, encodes an essential G1-specific cyclin of the main cell cycle kinase Cdc28. Interestingly, Cdc28-Cln3 had been previously linked to regulation of endocytosis and of hyphal development (Zeng et al., 2012), although it was also found to affect activity of the hyphal transcription factor Ume6 (Mendelsohn et al., 2017). A third gene identified in the screen, VPS15, encodes a regulator of endosome-to-Golgi retrograde transport (Liu et al., 2014), and could thus indirectly affect endocytosis as well.
The initial screen did not distinguish between suppression of germ tube induction vs. suppression of hyphal elongation. The kinetics were investigated in detail for the AKL1-overexpressing cells and the akl1−/− cells, and found to specifically involve hyphal elongation rather than initiation. A role for endocytosis in C. albicans hyphal growth had previously been suggested by the observations that several mutants in actin regulatory complexes affected both fluid phase endocytosis and hyphal morphogenesis, including notably Pan1 (Martin et al., 2007), as well as myosin type I Myo5 (Oberholzer et al., 2002), the Wiscott-Aldrich Syndrome Protein homolog Wal1 (Walther and Wendland, 2004), the verprolin Vrp1 (Borth et al., 2010), the BAR domain proteins Rvs161 and Rvs167 (Douglas et al., 2009), and the clathrin adaptor protein Sla2 (Gale et al., 2009). ARP2/3 deletions, which disrupt clathrin-mediated endocytosis while not affecting an alternative endocytic pathway, are also unable to form hyphae (Epp et al., 2010, 2013). The simplest explanation for a requirement for endocytosis in hyphal morphogenesis in general, is that the extensive exocytosis required for the rapid cell wall and cell membrane deposition at the tip of the extending hypha, needs to be counterbalanced by endocytosis in order to recycle the membranes and the proteins used in vesicle exocytosis (reviewed in Shaw et al., 2011). A higher requirement for endocytosis in hyphal growth, compared to yeast growth, would explain why the extent of suppression of endocytosis achieved by AKL1 overexpression is sufficient to significantly depress hyphal elongation, but not to affect C. albicans yeast growth and proliferation. In further support of a higher requirement for endocytosis in hyphal growth, we found that drugs that suppress endocytosis also suppress hyphal elongation at concentrations at which yeast proliferation remains unimpeded (Bar-Yosef et al., 2017).
While our results underscore the previous reports indicating that inhibition of endocytosis suppresses hyphal growth, we find in addition that the enhancement of fluid-phase endocytosis measured in the akl1−/− mutant and in cells overexpressing PAN1, are accompanied in both cases by accelerated hyphal elongation. This result was unexpected, and suggests that under standard hyphae induction conditions, endocytosis is limiting for optimal hyphal extension. We note however that, for the akl1−/− mutant tested in YPD medium at 37°C, the large initial increase in germ tube extension vs. wild-type cells (60% longer hyphae in akl1−/− after 1 h) is followed, during the second hour, by a smaller increase in hyphal elongation rates (24% faster elongation) in the absence of serum, or no difference at all in the presence of serum (Figure 3B). This observation suggests that under these conditions, the main contribution of the higher endocytosis rates of the akl1−/− mutant may lie in “priming” the cells for hyphal elongation. At later time points, endocytosis might be physiologically accelerated in the wild-type, nullifying the initial advantage of the akl1−/− strain, or alternatively, the larger hyphal cell bulk might make the relative endocytosis rate less rate-limiting for growth at the hyphal tip.
The faster germ tube extension in the akl1−/− cells and in the PAN1-overexpressing cells is accompanied by increased expression of hyphal-specific genes, whereas the decreased germ tube extension in the AKL1-overexpressing cells is accompanied by decreased HSG expression. Our model however suggests that Akl1 affects morphogenesis via its effect on endocytosis, rather than on HSG expression. This is further supported by the observation that ectopic induction of hyphal morphogenesis by UME6 expression, an inducer of HSGs, is blocked by AKL1 overexpression, suggesting that Akl1 functions downstream of the hyphal induction pathway. However, if Akl1 functions downstream of the transcriptional regulation of hyphal morphogenesis, why then is HSG expression affected by Akl1? One possibility is that in addition to its endocytic pathway substrates such as Pan1, Akl1 also phosphorylates substrates in the hyphal induction pathway. However, this does not explain the effect of overexpression of Pan1 itself on both hyphal elongation and HSG expression. Therefore, it is more likely that it is the enhancement of endocytosis per se, and the ensuing enhancement of hyphal extension, that causes hyperinduction of HSG expression, and conversely, reduction of hyphal elongation via reduction in endocytosis causes decreased HSG expression. This would imply that beyond the transcriptional control of hyphal morphogenesis, the hyphal morphogenetic apparatus can regulate the hyphal gene expression program via a feedback mechanism. Such a feedback mechanism has been proposed previously between the GTPase exchange factor Cdc24 involved in hyphal growth and the hyphal transcription apparatus (Bassilana et al., 2005). The recent observation that interference with cellular physiology such as e.g., cell cycle progression, long known to induce filamentous growth, can also induce the HSG expression program even in the absence of external stimulation (Woolford et al., 2016), further supports the existence of such a feedback system. While the nature of this mechanism in C. albicans is still unknown, direct effects of cytoskeleton structure on transcription factor activity have been described in other systems (Posern et al., 2002; Miralles et al., 2003).
Conceived and designed the experiments, HB-Y, TG, BR-Z, CS, JM, RA, and DK; Performed the experiments, HB-Y, TG, ZW, MP, RN, and DK; Analyzed the data, HB-Y, TG, ZW, and DK; Contributed reagents, materials analysis tools, TG, BR-Z and CS; DK Wrote the paper, with input from all the authors, who read and approved the final draft of the manuscript.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
This study was supported by an ERA-NET PathoGenoMics grant (KinCan) to RA, JM, and DK, and US-Israel Binational Science Foundation grant 2011361 to DK.
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcimb.2018.00017/full#supplementary-material
Albataineh, M. T., Lazzell, A., Lopez-Ribot, J. L., and Kadosh, D. (2014). Ppg1, a PP2A-type protein phosphatase, controls filament extension and virulence in Candida albicans. Eukaryotic Cell 13, 1538–1547. doi: 10.1128/EC.00199-14
Arana, D. M., Nombela, C., Alonso-Monge, R., and Pla, J. (2005). The Pbs2 MAP kinase kinase is essential for the oxidative-stress response in the fungal pathogen Candida albicans. Microbiology 151, 1033–1049. doi: 10.1099/mic.0.27723-0
Banerjee, M., Thompson, D. S., Lazzell, A., Carlisle, P. L., Pierce, C., Monteagudo, C., et al. (2008). UME6, a novel filament-specific regulator of Candida albicans hyphal extension and virulence. Mol. Biol. Cell 19, 1354–1365. doi: 10.1091/mbc.E07-11-1110
Bar-Yosef, H., Vivanco Gonzalez, N., Ben-Aroya, S., Kron, S. J., and Kornitzer, D. (2017). Chemical inhibitors of Candida albicans hyphal morphogenesis target endocytosis. Sci. Rep. 7:5692. doi: 10.1038/s41598-017-05741-y
Basrai, M. A., Naider, F., and Becker, J. M. (1990). Internalization of lucifer yellow in Candida albicans by fluid phase endocytosis. J. Gen. Microbiol. 136, 1059–1065. doi: 10.1099/00221287-136-6-1059
Biswas, K., and Morschhäuser, J. (2005). The Mep2p ammonium permease controls nitrogen starvation-induced filamentous growth in Candida albicans. Mol. Microbiol. 56, 649–669. doi: 10.1111/j.1365-2958.2005.04576.x
Borth, N., Walther, A., Reijnst, P., Jorde, S., Schaub, Y., and Wendland, J. (2010). Candida albicans Vrp1 is required for polarized morphogenesis and interacts with Wal1 and Myo5. Microbiology 156, 2962–2969. doi: 10.1099/mic.0.041707-0
Braun, B. R., Kadosh, D., and Johnson, A. D. (2001). NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction. EMBO J. 20, 4753–4761. doi: 10.1093/emboj/20.17.4753
Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G., and White, T. C. (2012). Hidden killers: human fungal infections. Sci. Transl. Med. 4:165rv113. doi: 10.1126/scitranslmed.3004404
Carlisle, P. L., Banerjee, M., Lazzell, A., Monteagudo, C., LLópez-Ribot, J. L., and Kadosh, D. (2009). Expression levels of a filament-specific transcriptional regulator are sufficient to determine Candida albicans morphology and virulence. Proc. Natl. Acad. Sci. U.S.A. 106, 599–604. doi: 10.1073/pnas.0804061106
Corvey, C., Koetter, P., Beckhaus, T., Hack, J., Hofmann, S., Hampel, M., et al. (2005). Carbon Source-dependent assembly of the Snf1p kinase complex in Candida albicans. J. Biol. Chem. 280, 25323–25330. doi: 10.1074/jbc.M503719200
Di Tommaso, P., Moretti, S., Xenarios, I., Orobitg, M., Montanyola, A., Chang, J. M., et al. (2011). T-Coffee: a web server for the multiple sequence alignment of protein and RNA sequences using structural information and homology extension. Nucleic Acids Res. 39, W13–W17. doi: 10.1093/nar/gkr245
Douglas, L. M., Martin, S. W., and Konopka, J. B. (2009). BAR domain proteins Rvs161 and Rvs167 contribute to Candida albicans endocytosis, morphogenesis, and virulence. Infect. Immun. 77, 4150–4160. doi: 10.1128/IAI.00683-09
Elson, S. L., Noble, S. M., Solis, N. V., Filler, S. G., and Johnson, A. D. (2009). An RNA transport system in Candida albicans regulates hyphal morphology and invasive growth. PLoS Genet. 5:e1000664. doi: 10.1371/journal.pgen.1000664
Epp, E., Nazarova, E., Regan, H., Douglas, L. M., Konopka, J. B., Vogel, J., et al. (2013). Clathrin- and Arp2/3-independent endocytosis in the fungal pathogen Candida albicans. MBio 4:e00476-13. doi: 10.1128/mBio.00476-13
Epp, E., Walther, A., Lepine, G., Leon, Z., Mullick, A., Raymond, M., et al. (2010). Forward genetics in Candida albicans that reveals the Arp2/3 complex is required for hyphal formation, but not endocytosis. Mol. Microbiol. 75, 1182–1198. doi: 10.1111/j.1365-2958.2009.07038.x
Gale, C. A., Leonard, M. D., Finley, K. R., Christensen, L., McClellan, M., Abbey, D., et al. (2009). SLA2 mutations cause SWE1-mediated cell cycle phenotypes in Candida albicans and Saccharomyces cerevisiae. Microbiology 155, 3847–3859. doi: 10.1099/mic.0.033233-0
Gola, S., Martin, R., Walther, A., Dünkler, A., and Wendland, J. (2003). New modules for PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region. Yeast 20, 1339–1347. doi: 10.1002/yea.1044
Hanaoka, N., Takano, Y., Shibuya, K., Fugo, H., Uehara, Y., and Niimi, M. (2008). Identification of the putative protein phosphatase gene PTC1 as a virulence-related gene using a silkworm model of Candida albicans infection. Eukaryotic Cell 7, 1640–1648. doi: 10.1128/EC.00129-08
Hu, K., Li, W., Wang, H., Chen, K., Wang, Y., and Sang, J. (2012). Shp1, a regulator of protein phosphatase 1 Glc7, has important roles in cell morphogenesis, cell cycle progression and DNA damage response in Candida albicans. Fungal Genet. Biol. 49, 433–442. doi: 10.1016/j.fgb.2012.04.004
Kempf, C., Bathe, F., and Fischer, R. (2013). Evidence that two Pcl-like cyclins control Cdk9 activity during cell differentiation in Aspergillus nidulans asexual development. Eukaryotic Cell 12, 23–36. doi: 10.1128/EC.00181-12
Leberer, E., Harcus, D., Broadbent, I. D., Clark, K. L., Dignard, D., Ziegelbauer, K., et al. (1996). Signal transduction through homologs of the Ste20p and Ste7p protein kinases can trigger hyphal formation in the pathogenic fungus Candida albicans. Proc. Natl. Acad. Sci. U.S.A. 93, 13217–13222. doi: 10.1073/pnas.93.23.13217
Lee, C. M., Nantel, A., Jiang, L., Whiteway, M., and Shen, S. H. (2004). The serine/threonine protein phosphatase SIT4 modulates yeast-to-hypha morphogenesis and virulence in Candida albicans. Mol. Microbiol. 51, 691–709. doi: 10.1111/j.1365-2958.2003.03879.x
Liu, Y., Solis, N. V., Heilmann, C. J., Phan, Q. T., Mitchell, A. P., Klis, F. M., et al. (2014). Role of retrograde trafficking in stress response, host cell interactions, and virulence of Candida albicans. Eukaryotic Cell 13, 279–287. doi: 10.1128/EC.00295-13
Lu, Y., Su, C., Unoje, O., and Liu, H. (2014). Quorum sensing controls hyphal initiation in Candida albicans through Ubr1-mediated protein degradation. Proc. Natl. Acad. Sci. U.S.A. 111, 1975–1980. doi: 10.1073/pnas.1318690111
Lu, Y., Su, C., Wang, A., and Liu, H. (2011). Hyphal development in Candida albicans requires two temporally linked changes in promoter chromatin for initiation and maintenance. PLoS Biol. 9:e1001105. doi: 10.1371/journal.pbio.1001105
Maidan, M. M., De Rop, L., Serneels, J., Exler, S., Rupp, S., Tournu, H., et al. (2005). The G protein-coupled receptor Gpr1 and the Galpha protein Gpa2 act through the cAMP-protein kinase A pathway to induce morphogenesis in Candida albicans. Mol. Biol. Cell 16, 1971–1986. doi: 10.1091/mbc.E04-09-0780
Martin, R., Hellwig, D., Schaub, Y., Bauer, J., Walther, A., and Wendland, J. (2007). Functional analysis of Candida albicans genes whose Saccharomyces cerevisiae homologues are involved in endocytosis. Yeast 24, 511–522. doi: 10.1002/yea.1489
Mendelsohn, S., Pinsky, M., Weissman, Z., and Kornitzer, D. (2017). Regulation of the Candida albicans hypha-inducing transcription factor Ume6 by the CDK1 cyclins Cln3 and Hgc1. mSphere 2:e00248-16. doi: 10.1128/mSphere.00248-16
Murad, A. M., Leng, P., Straffon, M., Wishart, J., Macaskill, S., MacCallum, D., et al. (2001). NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. EMBO J. 20, 4742–4752. doi: 10.1093/emboj/20.17.4742
Noble, S. M., and Johnson, A. D. (2005). Strains and strategies for large-scale gene deletion studies of the diploid human fungal pathogen Candida albicans. Eukaryotic Cell 4, 298–309. doi: 10.1128/EC.4.2.298-309.2005
Oberholzer, U., Marcil, A., Leberer, E., Thomas, D. Y., and Whiteway, M. (2002). Myosin I is required for hypha formation in Candida albicans. Eukaryotic Cell 1, 213–228. doi: 10.1128/EC.1.2.213-228.2002
Ofir, A., Hofmann, K., Weindling, E., Gildor, T., Barker, K. S., Rogers, P. D., et al. (2012). Role of a Candida albicans Nrm1/Whi5 homologue in cell cycle gene expression and DNA replication stress response. Mol. Microbiol. 84, 778–794. doi: 10.1111/j.1365-2958.2012.08056.x
Posern, G., Sotiropoulos, A., and Treisman, R. (2002). Mutant actins demonstrate a role for unpolymerized actin in control of transcription by serum response factor. Mol. Biol. Cell 13, 4167–4178. doi: 10.1091/mbc.02-05-0068
Ramírez-Zavala, B., Mottola, A., Haubenreißer, J., Schneider, S., Allert, S., Brunke, S., et al. (2017). The Snf1-activating kinase Sak1 is a key regulator of metabolic adaptation and in vivo fitness of Candida albicans. Mol. Microbiol. 104, 989–1007. doi: 10.1111/mmi.13674
Ramírez-Zavala, B., Weyler, M., Gildor, T., Schmauch, C., Kornitzer, D., Arkowitz, R., et al. (2013). Activation of the Cph1-dependent MAP kinase signaling pathway induces white-opaque switching in Candida albicans. PLoS Pathog. 9:e1003696. doi: 10.1371/journal.ppat.1003696
Seger, R., Seger, D., Reszka, A. A., Munar, E. S., Eldar-Finkelman, H., Dobrowolska, G., et al. (1994). Overexpression of mitogen-activated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. Evidence that MAPKK involvement in cellular proliferation is regulated by phosphorylation of serine residues in its kinase subdomains VII and VIII. J. Biol. Chem. 269, 25699–25709.
Stoldt, V. R., Sonneborn, A., Leuker, C. E., and Ernst, J. F. (1997). Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. EMBO J. 16, 1982–1991. doi: 10.1093/emboj/16.8.1982
Sun, L. L., Li, W. J., Wang, H. T., Chen, J., Deng, P., Wang, Y., et al. (2011). Protein phosphatase Pph3 and its regulatory subunit Psy2 regulate Rad53 dephosphorylation and cell morphogenesis during recovery from DNA damage in Candida albicans. Eukaryotic Cell 10, 1565–1573. doi: 10.1128/EC.05042-11
Sun, W., Kesavan, K., Schaefer, B. C., Garrington, T. P., Ware, M., Johnson, N. L., et al. (2001). MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 276, 5093–5100. doi: 10.1074/jbc.M003719200
Sun, Y., Leong, N. T., Wong, T., and Drubin, D. G. (2015). A Pan1/End3/Sla1 complex links Arp2/3-mediated actin assembly to sites of clathrin-mediated endocytosis. Mol. Biol. Cell 26, 3841–3856. doi: 10.1091/mbc.E15-04-0252
Takahashi, T., Furuchi, T., and Naganuma, A. (2006). Endocytic Ark/Prk kinases play a critical role in adriamycin resistance in both yeast and mammalian cells. Cancer Res. 66, 11932–11937. doi: 10.1158/0008-5472.CAN-06-3220
Uhl, M. A., Biery, M., Craig, N., and Johnson, A. D. (2003). Haploinsufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicans. EMBO J. 22, 2668–2678. doi: 10.1093/emboj/cdg256
Umeyama, T., Kaneko, A., Nagai, Y., Hanaoka, N., Tanabe, K., Takano, Y., et al. (2005). Candida albicans protein kinase CaHsl1p regulates cell elongation and virulence. Mol. Microbiol. 55, 381–395. doi: 10.1111/j.1365-2958.2004.04405.x
Walther, A., and Wendland, J. (2004). Polarized hyphal growth in Candida albicans requires the Wiskott-Aldrich syndrome protein homolog Wal1p. Eukaryotic Cell 3, 471–482. doi: 10.1128/EC.3.2.471-482.2004
Watters, M. K., Boersma, M., Johnson, M., Reyes, C., Westrick, E., and Lindamood, E. (2011). A screen for Neurospora knockout mutants displaying growth rate dependent branch density. Fungal Biol. 115, 296–301. doi: 10.1016/j.funbio.2010.12.015
Wendland, B., and Emr, S. D. (1998). Pan1p, yeast eps15, functions as a multivalent adaptor that coordinates protein-protein interactions essential for endocytosis. J. Cell Biol. 141, 71–84. doi: 10.1083/jcb.141.1.71
Wightman, R., Bates, S., Amornrrattanapan, P., and Sudbery, P. (2004). in Candida albicans, the Nim1 kinases Gin4 and Hsl1 negatively regulate pseudohypha formation and Gin4 also controls septin organization. J. Cell Biol. 164, 581–591. doi: 10.1083/jcb.200307176
Woolford, C. A., Lagree, K., Xu, W., Aleynikov, T., Adhikari, H., Sanchez, H., et al. (2016). Bypass of Candida albicans filamentation/biofilm regulators through diminished expression of protein kinase Cak1. PLoS Genet. 12:e1006487. doi: 10.1371/journal.pgen.1006487
Zeidler, U., Lettner, T., Lassnig, C., Müller, M., Lajko, R., Hintner, H., et al. (2009). UME6 is a crucial downstream target of other transcriptional regulators of true hyphal development in Candida albicans. FEMS Yeast Res. 9, 126–142. doi: 10.1111/j.1567-1364.2008.00459.x
Zeng, G., Wang, Y. M., and Wang, Y. (2012). Cdc28-Cln3 phosphorylation of Sla1 regulates actin patch dynamics in different modes of fungal growth. Mol. Biol. Cell 23, 3485–3497. doi: 10.1091/mbc.E12-03-0231
Keywords: Candida albicans, hyphae, endocytosis, Pan1, functional genomics
Citation: Bar-Yosef H, Gildor T, Ramírez-Zavala B, Schmauch C, Weissman Z, Pinsky M, Naddaf R, Morschhäuser J, Arkowitz RA and Kornitzer D (2018) A Global Analysis of Kinase Function in Candida albicans Hyphal Morphogenesis Reveals a Role for the Endocytosis Regulator Akl1. Front. Cell. Infect. Microbiol. 8:17. doi: 10.3389/fcimb.2018.00017
Received: 11 October 2017; Accepted: 12 January 2018;
Published: 08 February 2018.
Edited by:James Bernard Konopka, Stony Brook University, United States
Reviewed by:Aaron Neumann, University of New Mexico, United States
David Kadosh, University of Texas Health Science Center at San Antonio, United States
Copyright © 2018 Bar-Yosef, Gildor, Ramírez-Zavala, Schmauch, Weissman, Pinsky, Naddaf, Morschhäuser, Arkowitz and Kornitzer. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Daniel Kornitzer, email@example.com
†These authors have contributed equally to this work.